Contingent consideration fair value adjustment
ANI Pharmaceuticals·Business Segments·2 segments·Rolls up to Contingent consideration fair value adjustment
Breakdown
Segments
Generics and OtherView metric
Rare Disease and BrandsView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Generics and Other | $0 | $0 | $0 | $0 | $0 |
| Rare Disease and Brands | $0 | $0 | $0 | $0 | $0 |
| Total | — | — | — | — | — |